How foreign companies establish a route into Saudi Arabia

Regulatory information is provided for editorial and research purposes and should be verified directly with the relevant authority.

Entry into Saudi Arabia turns on whether a company sells through another organisation's licence or holds its own. The three structures are appointing a Saudi distributor, naming a local marketing authorisation holder, or incorporating a Saudi subsidiary. Each carries different consequences for regulatory responsibility, pricing, procurement access and pharmacovigilance.

Ministry of Investment approval gates entry for non-GCC investors before commercial registration. Many activities now permit full foreign ownership, though healthcare and life sciences carry additional ministry approvals. Devices separately require Medical Device Marketing Authorisation from the SFDA, held through a Saudi authorised representative, with the certificate belonging to the manufacturer rather than the agent.

Incorporation decides outcomes. Distributor arrangements reach the market quickly but transfer customer relationships and registration leverage. Incorporation carries higher cost and Saudisation obligations while retaining the marketing authorisation, the pricing file and the government relationship.